Search the Newsreel

GH Research PLC (GHRS) director receives 2,202 options at $0.025 strike

GH Research PLC director Dermot John Hanley was granted 2,202 share options with an exercise price of $0.025 per share. These options vested immediately but are not exercisable until August 11, 2028, and will expire on August 11, 2033. Following this transaction, Hanley directly …

GH Research PLC (GHRS) director receives 2,202 fully vested share options

GH Research PLC director Duncan Moore was granted 2,202 fully vested share options on August 11, 2026, with an exercise price of $0.0250 per ordinary share and an expiration date of August 11, 2033. Although immediately vested, these options are not exercisable until August …

GH Research PLC (GHRS) grants 102,202 share options to director Michael Forer

GH Research PLC (GHRS) director Michael Forer received two grants of share options totaling 102,202 Ordinary Shares, both with an exercise price of $0.0250 per share and expiring on August 11, 2033. One grant of 2,202 options is immediately vested but not exercisable until …

Archimedes Tech SPAC III (ARCI) shows $280M in trust and Q2 2026 net income

Lam Research Plans Labs to Handle 50% More Experiments

Lam Research (NASDAQ: LRCX) announced plans to invest over $3 billion in its global R&D lab network across the U.S., Asia, and Europe over the next five years. This expansion aims to increase experiment capacity by more than 50% and further compress product development …

Archimedes Tech SPAC Partners III Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Archimedes Tech SPAC (ATII) details $1.2B Forge Nano deal and $135M loss

Archimedes Tech SPAC Partners II Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Lam Research Announces Plans to Invest More than $3B to Expand Global Lab Network, Increase Innovation Velocity in the AI Era

Lam Research plans to invest over $3 billion in the next five years to expand its global R&D lab network, aiming to boost experiment capacity by more than 50% and accelerate innovation in the AI era. This expansion will compress product development cycles for …

Marchex (MCHX) revenue slips as it acquires Archenia in $10M note deal

Chip equipment maker Lam Research to invest more than $3 billion to expand R&D labs

Aug 13 (Reuters) - Lam Research said on Thursday it intends to invest more than $3 billion in ‌the next five years to expand its ‌global research and development lab network, as it seeks to increase ​experiment capacity and speed up product development. The …

SanDisk, Lam Research among market cap stock movers on Thursday

Thursday's market saw significant movement in various stocks across different market capitalizations. SanDisk (SNDK) and Lam Research (LRCX) rallied, while Alibaba (BABA) saw declines. The article highlights top movers in mega-cap, large-cap, mid-cap, and small-cap categories, attributing changes to news, earnings reports, and other …

Why Archer Daniels Midland (ADM) Is Back In The Spotlight

Archer-Daniels-Midland (ADM) is gaining attention after reporting strong Q2 sales and net income, alongside plans to expand North American oilseed crush capacity for renewable fuels. The company has seen a significant 35% year-to-date stock gain and a 37.48% one-year total shareholder return. While currently …

Archer Aviation Stock Has Surged 45% in the Past Month. Should You Buy Into the Rally?

Archer Aviation (NYSE: ACHR) stock has been red-hot of late. For much of the year, it's been doing poorly, but there have been some recent developments, including a deal to acquire multiple businesses from aircraft giant Boeing, which appear to have sparked renewed interest …

Lam Research, Applied Materials, and Camtek Rise After SanDisk Issues Bullish Financial Targets

Quick Read SanDisk's 80% gross margin targets and signed contracts covering two-thirds of FY2028 bits drove LRCX up 4%, the most direct equipment beneficiary. AMAT reports Q3 earnings after today's close, while KLAC has already surged 72% year-to-date as equipment stocks get re-rated on …

Lam Research Corp Stock (LRCX) Moved Up by 3.22% on Aug 13: Drivers Behind the Movement

Lam Research Corp (LRCX) saw a 3.22% stock increase driven by strong fourth-quarter fiscal results, a raised full-year outlook, and accelerating demand for AI infrastructure. The company's annual revenue reached $23.23 billion with a net profit of $7.27 billion, leading to increased price targets …

Interarch Building Solutions FY26 Results: Revenue up 30.55% to ₹1,89,800 Lacs

Archer Aviation CEO Signals Strong Outlook for Investors

Archer Aviation (NYSE: ACHR) still has a long road ahead. The upstart aircraft maker isn't generating meaningful revenue, remains unprofitable, and has yet to begin large-scale commercial operations. Yet CEO Adam Goldstein continues projecting confidence about the company's future, and unlike many early-stage aerospace …

Is Archrock Inc. (AROC) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before …

Acacia Research (ACTG) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Martin McNultyChief Financial Officer - Michael ZambitoGagnier Communications - Elizabeth Chaconas TAKEAWAYS Total Revenue -- $114.6 million, representing an increase from $51.2 million in …

FactSet Research Systems Maintains Quarterly Dividend at $1.16 a Share; Payable Sept. 17 to Holders of Record as of Aug. 31

FactSet Research Systems (FDS) has announced that it is maintaining its quarterly dividend at $1.16 per share. The dividend will be payable on September 17 to shareholders of record as of August 31. This news reaffirms the company's consistent return of capital to its …

Archer Daniels Midland Announces Planned Board Director Transition

Archer Daniels Midland (ADM) announced the planned transition of board director Lei Z. Schlitz, effective December 31, 2026, due to a material change in her employment, not any operational disagreement. This move aligns with the company's corporate governance guidelines, ensuring an orderly board composition …

Archer Materials Advances Potassium Biosensor With Early Blood Collection Study

Why Stocks Could Rally if PPI Inflation Comes in Below Expectations

Investors were in wait-and-see mode on Thursday. There's a lot riding on the looming wholesale inflation report. Economists expect the data to show producer prices rose at a rate of 4.9% last month, according to a FactSet poll. Continue Reading

FactSet Declares Dividend

FactSet Research Systems Inc. NORWALK, Conn., Aug. 13, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS | NASDAQ:FDS), a leading global intelligence and AI solutions provider to the financial markets, today announced that its Board of Directors approved a regular quarterly cash dividend of $1.16 per …

Gradient Capital Advisors LLC Sells 4,983 Shares of Lam Research Corporation $LRCX

Gradient Capital Advisors LLC reduced its stake in Lam Research Corporation by 24.2% in the second quarter, selling 4,983 shares and retaining 15,624 shares valued at $6.77 million. This comes as institutional investors hold 84.61% of LRCX, while company insiders have sold over $27 …

Wedge Capital Management L L P NC Takes Position in Archer Daniels Midland Company $ADM

Wedge Capital Management L L P NC has initiated a new position in Archer Daniels Midland Company (NYSE:ADM) by purchasing 88,490 shares valued at approximately $6.76 million. This move comes as other institutional investors have also adjusted their stakes in ADM, which reported strong …

Lam Research stock extends strong 2026 rally as AI-driven chip demand boosts earnings

Marchex forecasts $16M-$16.5M Q3 revenue following Archenia acquisition

Earnings Call Insights: Marchex, Inc. (MCHX) Q2 2026 MANAGEMENT VIEW * "The July 1 completion of Marchex's acquisition of Archenia marks an important step in our strategy to expand our AI-powered conversational intelligence and analytics solutions beyond insights and into actions and outcomes," said …

Assenagon Asset Management S.A. Boosts Stake in FactSet Research Systems Inc. $FDS

Arch Capital Group Ltd. (ACGL) Stock Forecasts

Argus has lowered its target price for Arch Capital Group Ltd. (ACGL) to $108.00. The company, a Bermuda-based insurer and reinsurer, operates across multiple regions including the United States, Canada, Europe, Australia, and the UK. The current stock price for ACGL is $97.45.

Assenagon Asset Management S.A. Buys 37,416 Shares of Arch Capital Group Ltd. $ACGL

Assenagon Asset Management S.A. significantly increased its stake in Arch Capital Group Ltd. by 295.6% in the second quarter, purchasing an additional 37,416 shares to bring its total holdings to 50,073 shares valued at $4.86 million. Despite mixed analyst ratings, Arch Capital has outperformed …

Ardsley Advisory Partners LP Invests $4.33 Million in Lam Research Corporation $LRCX

Ardsley Advisory Partners LP has acquired a new stake of 10,000 shares, valued at $4.33 million, in Lam Research Corporation during the second quarter, joining other institutional investors who collectively own 84.61% of the company. Despite significant insider selling totaling $27.6 million, analysts maintain …

Interarch Building Solutions targets ₹2,150 crore revenue in FY27

Archer-Daniels-Midland’s Q2 Earnings Call: Our Top 5 Analyst Questions

Archer-Daniels-Midland's Q2 Earnings Call: Our Top 5 Analyst Questions Archer-Daniels-Midland's second quarter saw a positive market reaction as the company outperformed Wall Street's expectations on both revenue and profit. Management attributed this performance to robust operational execution, notably in biofuels and oilseed processing, as …

NRC Health (NRC) Stock Price, News, Quote & History

This article provides a detailed overview of NRC Health (NRC) stock, including its current price, historical data, key financial metrics, and analyst ratings. It highlights the company's services in healthcare analytics and patient experience improvement, and compares its performance against the S&P 500. The …